Product 5
Natural health product licensed in Canada
- Licence holder
- Company 123
- NPN or DIN-HM
- 80085013
- Status
- Active licence
- Licence date
- 8 May 2018
- Revision date
- 29 October 2019
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Extrait de fève de café vert Source : Coffea arabica graine Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 1,625 mg Potency : 5 % Caffeine | 65 mg | Not calculated |
| Extrait de fève de café vert Source : Coffea arabica graine Potency : 45 % Chlorogenic acids | Not specified | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Silice, Hydroxypropylcellulose, Cellulose microcristalline, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Provides antioxidants. Helps maintain healthy blood pressure levels. Helps support cardiovascular health. Glucomannan promotes bowel movements by increasing bulk volume and water content. Glucomannan provides gentle relief of constipation and/or irregularity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or have difficulty swallowing.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are breastfeeding or have diabetes. Consult a health care practitioner if symptoms worsen or if laxative effect does not occur within 7 days. Consult a health care practitioner prior to use if you have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, diseases of the oesophagus and/or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, megacolon, faecal impaction, inflamed bowel or appendicitis).
Source
Official Health Canada record, licence 80085013
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging